Heterogeneity of the mechanisms of action of antidepressants

Author:

Kozlovskii V. L.1ORCID,Popov M. Yu.1ORCID,Kosterin D. N.1ORCID,Lepik O. V.1ORCID

Affiliation:

1. V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Abstract

The article discusses the heterogeneous mechanisms of the pharmacodynamics of antidepressants that underlie the therapeutic response. Sharing the similar clinical activity, antidepressants determine the development of drug-induced homeostasis by means of different molecular mechanisms (selective or nonselective blockade of monoamine reuptake, inhibition of monoamine oxidase, blockade of certain monoamine receptors). However, an increase of serotonin and other monoamines concentrations in the synapses of the central nervous system is only the initiating factor in the development of specific clinical effects. The latter are probably determined by other neurochemical effects, including changes in the density of postsynaptic receptors and an increase in the synthesis of neurotrophic factors. However, the primary mechanisms that increase monoamine concentrations in the synapses might not always “work properly”, leading to the lack of efficacy of the initial antidepressant, while the probability of the therapeutic response to the subsequent antidepressant remains rather high. Thus, the efficacy of an antidepressant may depend on the baseline differences in the neurochemical state contributing to the pathological “depressive” homeostasis. The heterogeneous neurochemical effects of antidepressants can determine the dissociation of existing neuronal interactions, leading to the development of the new — druginduced — homeostasis. At the same time, it is possible that stimulation of general neurotrophic processes by antidepressants may contribute to the progression and chronicity of pathology due to the ambiguous influence on certain stages of the pathological process. This determines the significance of neurophysiological studies of central disturbances in depression and search of fundamentally new neurochemical targets for the treatment of depressive states associated with various mental disorders.

Publisher

V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology

Reference30 articles.

1. Bekhtereva N.P., Kambarova D.K., Pozdeev V.K. Ustojchivoe patologicheskoe sostoyanie pri boleznyah mozga. L.: Medicina. 1978:240 (In Russ.)

2. Val’dman A.V., Poshivalov V.P. Farmakologicheskaya regulyaciya vnutrividovogo povedeniya. L.: Medicina. 1984:208. (In Russ.)

3. Kozlovskii VL. Receptor agonists/antagonists in the aspect of pathogenesis and pharmacotherapy of addictive disorders. Voprosy narkologii. 2014; 1:111-120. (In Russ.)

4. Kozlovskii VL, Kenunen OG. Studying the development of imipramine tolerance and prospects of its overcoming with the aid of tianeptine. Eksperimental’naya i klinicheskaya farmakologiya. 2014; 77(5):10-14. (In Russ.)

5. Kuchmenko DN, Kozlovskii VL. Pharmacodynamics of ketamine as a property of an «atypical antidepressant». Obozrenie psihiatrii i medicinskoj psihologii im. V.M. Bekhtereva. 2013; 4:20-25. (In Russ.)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3